Form 4: Clover Health Executive Conrad Wai Reports Stock Vesting

Clover Health Investments executive Conrad Wai reported the withholding of 23,463 shares to satisfy tax obligations following an RSU vest.

Summary

• Conrad Wai, CEO of Counterpart Health, reported the vesting of restricted stock units (RSUs) on April 15, 2026.
• A total of 23,463 shares of Class A Common Stock were withheld by the company to cover tax withholding obligations.
• Following this transaction, the reporting person maintains direct ownership of 1,169,914 shares and indirect ownership of 1,610,482 shares held in a family trust.
• The RSUs are part of a grant originally issued on October 15, 2024, which vest in quarterly installments of 6.25% through October 15, 2028.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event, as the share reduction was purely for tax compliance and does not reflect a discretionary sale of stock.

Positives

• The transaction reflects the ongoing vesting of equity compensation, aligning executive interests with long-term shareholder value.

Negatives

• The transaction resulted in a reduction of direct shareholdings, though this was strictly for tax compliance purposes.

Risks

• Continued vesting is subject to the reporting person's continued service with the company through October 15, 2028.

Future Outlook

The reporting person continues to hold a significant equity stake, with remaining RSUs scheduled to vest quarterly until October 2028, contingent upon continued service.

Management Comments

• The transaction was an automatic withholding of shares to cover tax obligations related to the vesting of previously granted RSUs.

Industry Context

StockSavvy.ai notes that routine tax-related share withholding is a standard administrative procedure for executives and does not typically signal a change in management sentiment regarding the company's outlook.

Comparison to Industry Standards

• The use of automatic share withholding for tax obligations is a standard practice among U.S. publicly traded companies to manage executive compensation tax liabilities.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors as this is a routine equity compensation event.

Next Steps

• Quarterly vesting of remaining RSUs continues through October 15, 2028.

Key Dates

Keywords

Clover Health, CLOV, Insider Trading, Form 4, Equity Compensation, Conrad Wai